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• Midget-faded rattlesnake envenomation is an uncommon occurrence. 
• Myo-neurological symptoms may result from Midget-faded rattlesnake envenomation. 
• Stress-induced physiological responses may result following a rattlesnake bite. 
• Venom-induced and stress-induced effects may cause a diagnositic conundrum.  












































Crotalus oreganus concolor is a small species of North American rattlesnake, indigenous 
to a confined middle region of the western United States. Reports of envenomation to humans 
are quite rare, and studies regarding the toxicity and pharmacological actions of C. o. concolor 
venom have shown the presence of a presynaptic PLA2-based neurotoxin, low molecular weight 
myotoxins with myotoxic effects, and very low metalloproteinase (SVMP) activity.  A case of 
envenomation that resulted in what appeared as potentially venom-induced myo-neurological 
symptoms is described. The patient sustained a single fang puncture from the bite of a captive C. 
o. concolor to the right thumb while pulling open a drawer-type housing unit to examine the 
snake.  Shortly thereafter, while being transported via ambulance, the patient experienced blurry 
vision, total body paresthesia, dyspnea, chest tightness, and three waves of spastic muscle 
movements that involved the hands and feet, and appeared as tetanic-bursts. These symptoms 
had resolved spontaneously prior to arrival at the hospital. Local envenomation effects at the bite 
site were evidenced as swelling, mild ecchymosis, pain, and numbness of the thumb persisted for 
greater than a week. The observed paresthesia and tetanic-burst symptoms were confounding as 
to which were potentially venom-induced or were related to stress-induced physiological 
responses. The patient’s laboratory values and coagulation parameters remained within normal 
limits, other than a slightly elevated D-dimer and moderately elevated creatine kinase. 
Coagulopathic symptoms or bleeding were not observed. Antivenom was not administered at any 
stage for various reasons and symptoms were successfully managed symptomatically.  Venom 
from the offending snake was collected and venom analysis revealed the presence of high levels 
of myotoxins, small peptides that can induce rapid tetanic limb muscle contractions in mice, and 
myokymia or fasciculations in humans. Concolor toxin, a presynaptic neurotoxin that can cause 
respiratory paralysis and myotoxic effects, and several serine proteinases often associated with 
coagulopathies, were also present. 
 
 



























The Midget-Faded Rattlesnake (Crotalus oreganus concolor) is a small (50-65 cm total 
body length) subspecies with a muted beige and tan color pattern that was originally assigned to 
the Crotalus viridis complex. Currently, it is recognized as a subspecies in the Crotalus oreganus 
clade (Ashton, 2001; Parker and Anderson, 2007). It is indigenous to a small geographic range of 
the Colorado Plateau that includes west-central Colorado (including the Colorado and Green 
river basins), eastern Utah, and southwestern Wyoming (Woodbury 1929, 1958).  More recently, 
its range has been extended into extreme northern Arizona (Brennen, 2004).  
 
Early studies of C. o. concolor venom revealed the presence of potent lethal Mojave 
toxin-like components, and it was found to be one of the most lethal crotaline venoms, nearly 
equal in toxicity to Crotalus durissus terrificus and Crotalus scutulatus scutulatus venoms, based 
on the results of murine lethality experiments (Glenn, 1977). An antigenically similar toxin to 
Mojave toxin has been isolated from C. o. concolor venom (Pool and Bieber 1980, Weinstein et 
al. 1985). Additionally, it has been reported that C. o. concolor venom lethality has ranged from 
10-30 fold greater than that of C. o. abyssus, C. o. caliginis, C. o. cerberus, C. o. helleri, C. o. 
lutosus, C. o. oreganus, C. v. nuntius, and C. v. viridis (Glenn 1977; Mackessy et al., 2003).  
Presynaptic phospholipase A2 beta neurotoxin (concolor toxin) and non-enzymatic peptide 
myotoxins have been identified as major venom components with potent lethal pharmacological 
activities (Mackessy et al., 2003; Mackessy, 2010; Modahl and Mackessy, 2016; Pool and 
Bieber, 1981). 
 
Well-documented cases of human envenomation by C. o. concolor have rarely been 
reported, and fatalities are not found in the literature.  Myotoxic and neurological symptoms have 
been reported in two cases, and involved ataxia, facial and perioral numbness, and numbness that 
radiated down through the torso (Mackessy et al., 2003). A single case has been reported in 
which there was myokymia (Lovecchio et al., 2005). 
 
The case of envenomation from the bite of C. o. concolor reported here illustrates what 
clinically appeared to be potential venom-induced myo-neurological symptoms that were 
confounded by non-venom-induced effects related to hyperventilation and hypocalcemia. An 
analysis of the venom from the offending snake suggested a possible correlation between 





An adult captive (wild caught - exact locality unknown) C. o. concolor (Fig. 1 A) 
inflicted a bite to a healthy 61-year-old Caucasian male, professional herpetologist. The patient 
had a history of prior crotaline envenomations: one Crotalus horridus, one C. h. atricaudatus 
(subspecies recognized at the time of the bite) and one Crotalus durissus ruruima), in addition to 
other envenomations that involved several other genera of venomous snakes (Agkistrodon, 
Atractaspis, Naja, and Vipera). These had also involved treatment with various antivenom 
products (Instituto Butantan Anticrotalico, Wyeth Anticrotalic (twice), and SAIMR Polyvalent), 
with anaphylactic reactions following antivenom administration in three separate instances. 
Patient prescribed medication history included atenolol, rizatriptan as needed, and amitriptyline 
at night for migraine suppression.  
The incident took place in a remote rural setting, and the bite having occurred when the 
snake was being removed from a drawer-type housing unit, with a single fang penetration into 




Fig 1. Panel A: The Midget Faded Rattlesnake (Crotalus oreganus concolor), responsible for the 
bite, in its housing drawer enclosure from which it struck, impaling a single fang puncture to the 







Immediately following the bite, the patient experienced generalized “pins and needles” sensation 
in the bitten thumb, followed shortly by tingling of the lips, and reported feeling chest tightness. 
Within fifteen minutes the patient reported entire body tingling. The first responder found the 
patient supine on the cool concrete floor, and reported that the patient did not appear to be overly 
anxious or agitated. Respirations and pulse were normal to slow, and there were no obvious signs 
of hyperventilation. The patient described feeling like he was, “wearing a clay mask and a hat 
with hat band one size too small constricting around my forehead”. The affected limb was 
splinted to maintain immobilization followed by a one-hour ground ambulance transport to the 
helispot, and a subsequent one-hour helicopter flight to a rural hospital. En route via ground 
ambulance transport the patient complained of breathing difficulty, and supplemental oxygen 
was provided via placement of a nasal cannula.  Additionally, tightening of the tongue, blurred 
vision, and difficulty speaking were experienced by the patient. The paresthesias were 
accompanied by three separate waves of transient neuromuscular spasms that also appeared to 
affect both smooth and skeletal muscles (inspirational weakness). Spastic contractures of first the 
left hand, then on a second separate occasion the left hand again, and to lesser degree the right 
(bitten) hand and toes, followed by a third separate wave to the left forearm and lower leg. The 
first responder reported these as waves of severe spastic muscle movement that appeared to be 
tetany-like (Fig 2 A). These symptoms began approximately 30 minutes post bite, each episode 
lasted less than10 minutes, and they occurred approximately 20-30 minutes apart. The patient 
was alert and oriented, simultaneous hand and foot cramping were observed, with blood pressure 
and pulse normal to low by palpitation and sphygmomanometer/cuff (Fig 2 B).  The patient 
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reported chest and head pressure with breathing difficulties, slight blurring of vision, local pain, 
and total body tingling.  
 
 
Fig 2. Panel A: Tetany-like spasms showing flexion of the hands and extenision of the feet 
(carpopedal spasms) that began 30 minutes post bite.  Three waves of approximately 10 minutes 
each, 20 minutes apart, were observed. Panel B: Blood pressure and pulse were normal to low as 






Three hours post bite the patient arrived in the emergency department. The apparent 
waves of myo- and neurological (hand and foot, upper and lower limb contractures and 
extensions) observed during transport were transient and had abated. Only a single fang 
puncture, with local swelling that extended proximally from the right thumb to the thenar 
eminence, was evident upon examination. Laboratory results for all parameters on admission 
were within normal limits excepting a slightly elevated D-dimer value of 566 ng/mL FEU (lab 
range 190-490 ng/mL FEU), and elevated creatine kinase (CK) value of 3394 U/L (lab range 22 
to 198 U/L). Additionally, there was a gradual decline in total calcium from 8.8 mg/dL at 
admission (reporting laboratory range 8.5-10.1 mg/dL) to 8.1 (7.5 hrs), 7.9 (13.5 hrs), and 7.7 
(22 hrs), with a corresponding decline in serum albumin from 4.2 g/dL at admission (reporting 
laboratory range 3.4-5.0 g/dL), to 3.6 g/dL (7.5 hrs), to 3.5 g/dL at 22 hrs (Fig. 3).  Antivenom 
was not administered per the patient’s request, and because his clinical symptoms appeared to 
have resolved. The swelling continued to spread proximally over the next few hours, reaching to 
mid-forearm at its furthest, but the local pain had lessened. However, the patient was observed to 
have considerable loss of total body strength, coordination was poor, and a Walker/Zimmer 
frame was required to stand. There was no evidence suggestive of compartment syndrome. The 
patient was observed for another 6 hours and discharged home at 25 hours post envenomation 
(22 hours post admission) in a stable condition. At 24 hours after discharge the patient was weak, 
but able to walk slowly without assistance. He continued to experience myalgias in the right arm 
and overall generalized weakness for the next few days. A few weeks later, sloughing of skin 
around the bite site was observed, but other than numbness of the thumb, all other local 
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Fig 3. Patient total serum albumin and calcium levels showing a gradual decline over the 24-hour 







Venom was extracted manually from the offending C. o. concolor approximately 4 days 
after the bite occurred, centrifuged to pellet cell debris and then lyophilized; the yield was 
approximately 120 µL, corresponding to approximately 27 mg dry venom. Venom solubilized in 
PBS at 8.0 mg/mL, and 200 µL (1.6 mg) was subjected to reversed phase high performance 
liquid chromatography (RP-HPLC) as reported previously (Smith and Mackessy, 2016); one-
minute fractions were collected and lyophilized. Toxins were identified from the known elution 
profiles of purified toxins and quantified via peak area integration (% total area). 
 
HPLC fractions were also subjected to polyacrylamide gel electrophoresis under reducing 
conditions (SDS-PAGE; Smith and Mackessy, 2016) to identify chromatogram peaks. Crude 
venom was assayed for protein content via Pierce® BCA assay (Smith et al., 1985) and then for 
six enzyme activities common to rattlesnake venoms (Mackessy, 2010). These data were used in 
conjunction with HPLC chromatogram data to identify protein families present and their relative 
abundance in the venom.  
 
Results and Discussion 
 
The case presented is perplexing in that it illustrates a diagnostic conundrum that 
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snakebite patient: what symptoms might be the result of venom-induced effects, and what 
symptoms might be related to other stress-induced physiological responses? Available detailed 
literature regarding envenomation by C. o. concolor is limited; however, symptoms previously 
reported following envenomation by this species reveal similarities and differences with those 
observed in the current case (Lovechio et al., 2005; Mackessy et al., 2003). Crotalus o. concolor 
venom has been shown to contain myotoxic and neurotoxic venom components, and 
envenomation is capable of eliciting neurotoxic symptoms (Mackessy, 2003, 2010; Modahl and 
Mackessy, 2016; Pool and Bieber, 1981). Thus, assessment of cause with respect to the observed 
symptoms in the presented case, combined with the interpretation of the analytical results of 
venom derived from the snake that inflicted the bite, provide for an interesting discussion. 
 
The acuity and complexity of the symptoms experienced by our patient following the bite 
are confounding.  Blurred vision, total body paresthesia, breathlessness and chest tightness, 
waves of spastic tetanic bursts of the hands with extension of the feet, and the generalized 
weakness with poor coordination suggests that they were symptomatic components potentially 
related to venom-induced systemic toxicity. Purified C. o. concolor venom toxins injected into 
mice have been reported to elicit myotoxic effects such as rapid ataxia and hind limb extension 
(Ownby et al., 1988). In contrast, some of these similar initial ensuing symptoms such as the 
patient’s tetanic bursts, which could be described as carpopedal spasms, may not have been 
venom-induced, but rather have potentially resulted from patient anxiety-induced 
hyperventilation. These myoneurological symptoms could also have been triggered by 
sphygmomanometer cuff inflation (Mrunalini et al., 2014; Rehman and Wunder, 2011). 
Additionally, the symptoms of blurred vision, weakness, perioral paresthesia, and difficulty 
breathing have also been reported in other cases of North American rattlesnake envenomation, 
including C. o. concolor envenomation (Bush and Siedelburg, 1999; LoVecchio et al., 2005). 
 
Venomous snakebite to a human is a serious medical event, and can trigger significant 
anxiety in the unfortunate victim. Consequently, the clinical presentation of neurotoxicity can be 
clouded and confounded by the emotional response of a snakebite victim. Anxiety can lead to 
patient hyperventilation-induced alkalemia (respiratory alkalosis) with consequent precipitation 
of hypocalcemia (Mrunalini et al., 2014). This condition can result in symptoms of 
breathlessness and paresthesia of the face and hands, while blood pressure remains normal. 
Tetany-like symptoms may be evidenced by painful sharp flexion of the wrist and ankle joints 
(carpopedal spasms), cramps, muscle twitching, and seizures with associated stridor, occurring in 
response to the hyperexcitability state of muscles and nerves due to decreased extracellular 
ionized calcium (Mrunalini et al., 2014). Although ionized calcium was not measured in the 
current case, the patient’s total calcium declined within 24 hrs from 8.8 mg/dL to 7.7 mg/dL, and 
in parallel serum albumin declined from 4.2 g/dL to 3.5 g/dL, respectively (Fig. 3). Our patient 
was not observed to be hyperventilating as evidenced by tachypnea; however, hyperventilation 
may also occur via slow deep breathing, which is not always readily observable in emergent 
situations. Hypocalcemic tetany of the lower extremities has been reported in a case of Crotalus 
scutulatus envenomation, and with minimal coagulopathy. However, it was thought to have been 
subsequent to rhabdomyolysis (Bush and Jansen, 1995). Thus, an anxious snakebite victim may 
over ventilate to the point of respiratory alkalosis followed by hypocalcemic tetany, while 
maintaining a normal blood pressure. Several of the neurological symptoms observed in our 
patient fit the profile of these stress-related physiological responses, which cannot be ruled out as 
a contributing root of cause.  
 
The monitoring of vital signs in venomous snakebite patients, specifically blood pressure 
measurements, often involves the use of a sphygmomanometer with an inflatable cuff. Our 
patient had his blood pressure monitored during ambulance transport, and the question of 
whether or not the inflation of the cuff, in conjunction with hyperventilation-induced 
hypocalcemia, triggered a classic Trousseau sign also has to be considered (Rehman and 
Wunder, 2011). Cuff inflation to greater than the mean arterial pressure can result in the hand 
adopting a characterized posture of flexion of the metacarpophalangeal joints, with the 
interphalangeal joints of the fingers and thumb extended so that the thumb is in an opposing 
posture, as observed in our patient (Fig. 2B). This phenomenon has been reported to occur in 1-
4% of healthy individuals (Habib and Wunder, 2014), and has not been reported to occur in cases 
of venomous snakebite. Again, the possibility of this observed symptom having been a stress-
induced response rather than venom-induced must be considered.  
 
In parallel to stress-induced symptoms, an evaluation of our patient’s potentially venom-
induced symptoms must be considered. It is possible that some of the myo-neurotoxic symptoms 
observed following the envenomation were experienced due to the confirmed presence of high 
myotoxin content in the venom of the C. o. concolor (Figs. 4, 5). The potent neurotoxin, 
concolor toxin, is known to be present in C. o. concolor venom, and the myotoxic components of 
C.o. concolor venom possess muscle contractile activity, causing rapid tetanic-like hind limb 
hyperextension in mice, a venom/toxin-induced symptom, which is similar to, and may be 
confused with, the symptoms observed in our patient as evidenced by the extension of the ankles, 
feet, and toes (Hayes and Bieber, 1986; Ownby et al., 1988). Additionally, the rapidity of death 
from respiratory failure observed in mice injected with C. o. concolor venom suggests the 
possibility that the patient could potentially have experienced “air hunger” from incipient 
respiratory distress, which fortunately did not progress to more serious respiratory compromise 
in our patient. Respiratory insufficiency in human rattlesnake bite victims has been reported to 
occur following Crotalus scutulatus, Crotalus cerastes, Crotalus helleri, and Crotalus horridus 
envenomations (Bosak et al., 2014; Bush and Siedenburg, 1999; Clark et al., 1997; Madey et al., 
2013).  
 
The actual venom dose delivered with the bite to our patient is indeterminable, but since 
venom was injected via a single fang puncture it would be reasonable to assume a maximum 
venom dose was not delivered with the bite. The less-than-fully injected venom volume was 
likely responsible for the reduced severity and duration of envenomation symptoms observed. 
Importantly, snake venoms do not contain a single homogeneous toxin and the pharmacokinetics 
of individual myo- and neurotoxins in C. o. concolor venom are not known. As such, it is 
possible that the short duration of myo-neurological symptoms observed in our patient was 
related to dose-dependent pharmacokinetics of a responsible toxin, or pharmacokinetic metabolic 
actions on the responsible venom toxin(s). Although our patient’s myo-neurological symptoms 
were of short duration, it is well documented that the duration of neurotoxic effects following 
envenomation is highly variable (Ranawaka et al., 2013).  
 
Myokymia has been a reported symptom following envenomation by C. o. concolor and 
other species of North American rattlesnakes (Brick et al., 1987; LoVecchio et al., 2005; Vohra 
et al. 2008). In our patient, the periodic episodes of tetanic-like, carpopedal spasms, separated 
many minutes apart, appeared to be distinctly different than myokymia or fasciculations, which 
typically appear as sustained wave-like movements that typically involve muscle groups near the 
site of envenomation on the bitten extremity, or facial muscles, and can lead to respiratory 
compromise (LoVecchio et al., 2005; Vohra et al., 2008).  Our patient did not exhibit these 
sustained wave-like undulations as observed clinically. 
 
Neurological symptoms following C. o. concolor envenomation have been anecdotally 
reported to have occurred rapidly, and involved facial numbness that radiated down the arm, and 
the patient having complications with maintaining balance (Mackessy et al., 2003). Similar 
symptoms of persistent paresthesia, weakness, and distal extremity numbness have also been 
reported following Crotalus cerastes envenomation (Bosak et al., 2014). Our patient experienced 
generalized paresthesia of significant duration and breathing difficulties, and his generalized 
weakness persisted for days following the bite. These symptoms are consistent with the 
possibility that in our patient they were the result of a venom-induced effect.  
 
Hematological complications were not observed in the patient presented here. However, 
cases of severe rattlesnake envenomation with significant neurological effects, and an absence of 
hematological effects following Crotalus cerastes envenomation, or only minimal hematological 
effects, have been reported (Bosak et al., 2014, Bush and Siedelburg, 1999). In the limited 
number of cases of C. o. concolor envenomation reported, coagulopathy was not always evident 
or reported (LoVecchio et al., 2005; Mackessy et al., 2003). As such, the absence of 
hematological effects in our patient does not exclude the fact that some degree of envenomation 
occurred.  
 
Local wound complications in our patient were modest with slight ecchymosis, swelling, 
pain, and skin sloughing, and were not unlike those reported following other reported cases of 
rattlesnake envenomation. Quantitation of serum creatine kinase (CK) is a routinely used clinical 
and laboratory marker for assessing tissue damage and myonecrosis (Mebs et al., 1983).  Our 
patient’s elevated CK value (3394 U/L) reported at 22 hrs post envenomation was likely the 
result of local tissue/muscle damage at the envenomation site on the thumb. Similar elevation of 
CK has been reported following C. o. concolor envenomation, and in the absence of 
coagulopathic complications (Lovecchio et al., 2005). Thus, these local tissue damage effects 
were venom-induced effects in our patient. 
 
Medications taken by patients can potentially influence the effects of snake 
envenomation (Ostapenko et al., 2001; Schulte et al., 2018). Our patient was using, as 
prescribed, several medications (atenolol, rizatriptan, and amitriptyline for migraine 
suppression), and these could potentially exhibit a few adverse effects similar to the symptoms 
observed following the bite. Although blurred vision, numbness, chest tightness, paresthesia, and 
weakness may occur with the use of any of these medications (U.S. Food & Drug 
Administration), the patient reported having no adverse effects to any of these medications prior 
to the bite. Potential interactions of these medications with venom components, which could 
result in the causality of any the reported patient’s symptoms cannot be ruled out completely, but 
would seem unlikely.  
 
 The venom of C. o. concolor has been reported to contain PLA2-based ß neurotoxin 
(concolor toxin), and nonenzymatic peptide myotoxins (Bieber et al., 1987; Mackessy et al., 
2003; Pool and Bieber, 9181). The case reported here resulted from the bite of a wild-caught 
captive specimen, and provided an unusual opportunity to determine if venom components and 
toxins fractionated via high pressure liquid chromatography were present in sufficient quantities 
to potentially induce the myo- and neurological effects observed in our patient.  
 
Enzyme analysis of the C. o. concolor venom sample revealed that six enzymes common 
to rattlesnake venoms were present (Table 1); however, their levels varied significantly from 
averaged values based on 22 taxa of rattlesnakes (Mackessy, 2008).  
Notably, snake venom metalloproteinase activity (SVMP; azocasein metalloproteinase) was 
barely detectable, and the presence of only trace amounts of this common rattlesnake venom 
component is likely responsible for the lack of significant levels of hemorrhage, rhabdomyolysis 
and inflammation. These very low levels of SVMPs are characteristic of type II venoms, 
including that of C. o. concolor (Mackessy, 2010). Thrombin-like and kallikrein-like serine 
proteinase activities in the venom were quite high, and thrombin-like activity was nearly twice 
the average value of many rattlesnake venoms. Because of these high levels of activity, 
coagulopathies including hypofibrinogenemia would have been expected; however, lab blood 
panels did not indicate that any form of coagulopathy had occurred. Phospholipase A2 levels 
were moderate but not noteworthy compared to other species; PLA2 activity is sometimes 
associated with severe inflammation, myotoxicity and occasionally renal damage/failure. The 
lack of these symptoms indicates that this acidic PLA2 was not particularly toxic, consistent with 
similar enzymatic PLA2s from other species. 
 
Table 1. Assays of Crotalus o. concolor venom for enzyme activities common to rattlesnake 
venoms. Activity levels in the offending venom relative to averages of 22 taxa of rattlesnakes 
(Mackessy, 2008) are also indicated. 
 
 
Enzyme Assayed        Specific Activity      Relative Act.  
Phospholipase A2 (nmol product/min/mg)      25.38   ↓ 
 
Azocasein metalloproteinase (Abs 342nm/min/mg)          0.01   ↓↓ 
 
Kallikrein-like (nmol product/min/mg)            970.87   ↑↑ 
 
Thrombin-like (nmol product/min/mg)          1388.80   ↑↑ 
 
Phosphodiesterase (Abs 400nm/min/mg)             0.97   ↑ 
 
L-amino acid oxidase (nmol product/min/mg)    9.65   ↓ 
              
↓, venom lower than average; ↑, venom higher than average  
 
 
RP-HPLC analysis of the offending snake’s venom (Fig. 4) indicated the presence of 
myotoxins I & II (Bieber et al., 1987), small peptide components common to the venoms of 
numerous species of rattlesnakes. These myotoxins show potent activity in mammals, causing 
hyperextension of limbs in mouse models (Ownby et al., 1988). In humans, they may be 
responsible for fasciculations [possibly muscle weakness, both acute and prolonged] (Ranawaka 
et al., 2013). The myotoxin content of this venom was extremely high and comprised more than 
59% of the total venom proteins (Fig. 5). This venom also contained concolor toxin, a 
heterodimeric presynaptic neurotoxin with very high sequence identity to Mojave toxin 
(Crotalus scutulatus) and crotoxin (Crotalus durissus terrificus); concolor toxin made up more 
than 21% of the venom total protein content (Figs. 4, 5). The combined actions of these two 
protein families, which comprised >80% of venom proteins, are likely responsible for the rapid 










Fig 4. RP-HPLC chromatogram of C. o. concolor venom, 1.6 mg in 200 µL PBS. Identification 
of peaks are based on SDS-PAGE and enzyme activity assays. Inset: reducing SDS-PAGE of 






 Serine proteinases are common components of viper venoms, and they accounted for 
~8.6% of total venom proteins in the offending C. o. concolor in this case (Figs. 4, 5, Table 1). 
Given their relative abundance and high activity levels in this venom, it is surprising that 
coagulopathy-related symptoms more pronounced than the slightly elevated D-dimer did not 
develop. Several other proteins, including an acidic PLA2 (6.3%) and several unidentified 
proteins (2.9%), were observed following HPLC and SDS-PAGE, but it is unlikely that they 
contributed significantly to observed symptoms. 
 
Fig 5. Protein family composition of Crotalus oreganus concolor venom. Pie chart represents the 
relative abundance of proteins from different toxin families in the venom of the offending snake. 
ConTx A, concolor toxin subunit A; ConTx B, concolor toxin subunit B; PLA2, phospholipase 






 In conclusion, the presented case revealed that some of the observed symptoms, with 
respect to both myo-neurological and hematological symptoms, and local tissue effects, were not 
unlike some of the symptoms in other reported cases of C. o. concolor envenomation. The 
venom profile of the offending snake showed a high myotoxin content, and in this case suggests 
its potential contribution toward some of the venom-induced myo-neurological symptoms. The 
case reported here is an interesting academic case in that certain symptoms, similar to previously 
reported C. o. concolor cases of envenomation, were integrated with anxiety and stress-induced 
symptoms. Additional detailed laboratory analyses and patient neurological evaluation would 
have provided for a more comprehensive assessment and defined delineation for confirming the 
source(s) of the patient’s symptoms. Thus, a diagnostic conundrum was evident, and medical 
personnel should be cognizant of the potential for confounding symptoms to be observed when 
confronted with treating venomous snakebite patients. 
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